BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4872 related articles for article (PubMed ID: 6263209)

  • 1. Modern problems of clinical chemotherapy of malignant tumours.
    Perevodchikova NI; Bychkov MB
    Arch Geschwulstforsch; 1980; 50(7):657-63. PubMed ID: 6263209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.
    Beretta G; Bonadonna G; Bajetta E; Tancini G; De Lena M; Azzarelli A; Veronesi U
    Cancer Treat Rep; 1976 Feb; 60(2):205-11. PubMed ID: 769975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma].
    Kogoniia LM; Moroz LV; Perevodchikova NI; Platinskiĭ LV; Borisov AI
    Vopr Onkol; 1981; 27(4):16-21. PubMed ID: 7015692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
    Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC
    Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of chemotherapy of soft tissue sarcoma in adults].
    Santoro A; Viviani S
    Radiol Med; 1984 Nov; 70(11):893-5. PubMed ID: 6399763
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined chemotherapy of disaeminated melanoma].
    Moroz LV; Assekritova IV; Brazhnikova EI; Vaarik KhM; Voznyĭ EK
    Vestn Akad Med Nauk SSSR; 1978; (5):9-19. PubMed ID: 676469
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas.
    Creagan ET; Hahn RG; Ahmann DL; Edmonson JH; Bisel HF; Eagan RT
    Cancer Treat Rep; 1976 Sep; 60(9):1385-7. PubMed ID: 189922
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combination chemotherapy of disseminated skin melanoma with nitrosomethylurea].
    Perevodchikova NJ; Moros LW; Kogonia LM
    Arch Geschwulstforsch; 1986; 56(4):273-81. PubMed ID: 3530176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single drug and combination chemotherapy in the treatment. Disseminated malignant melanoma.
    Aranha GV; Grage TB
    Minn Med; 1977 Aug; 60(8):543-8. PubMed ID: 882082
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dacarbacine (DTIC) in the therapy of a malignant disease. A review (author's transl)].
    Huber H; Grünewald K
    Wien Klin Wochenschr; 1978 Dec; 90(24):861-4. PubMed ID: 369151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.
    De Wasch G; Bernheim J; Michel J; Lejeune F; Kenis Y
    Cancer Treat Rep; 1976 Sep; 60(9):1273-6. PubMed ID: 65222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adriamycin in the combined chemotherapy of small-cell lung cancer].
    Perevodchikova NI; Bychkov MB; Ausekar BV
    Antibiotiki; 1983 Aug; 28(8):628-32. PubMed ID: 6314882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study.
    Beretta G; Bonadonna G; Cascinelli N; Morabito A; Veronesi U
    Cancer Treat Rep; 1976 Jan; 60(1):33-40. PubMed ID: 1000518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclical combination chemotherapeutic regimen in adult soft tissue sarcoma.
    Dalley DN; Levi JA; Nesbitt RA; Tattersall MH; Woods RL; Fox RM; Aroney RS
    Cancer Clin Trials; 1981; 4(2):163-5. PubMed ID: 7249252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of metastasising soft-tissue sarcoma with a uniform combination chemotherapy of cyclosphosphamide, vincristin, adriamycin and DTIC ("CyVADIC") (author's transl)].
    Schmidt M; Sodomann CP; Gropp C; Havemann K
    Dtsch Med Wochenschr; 1978 Jul; 103(30):1206-10. PubMed ID: 668561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy.
    Everall JD; Dowd PM
    Cancer Treat Rep; 1979 Jan; 63(1):151-5. PubMed ID: 84710
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung.
    Bernath AM; Cohen MH; Ihde DC; Fossieck BE; Matthews MJ; Minna JD
    Cancer Treat Rep; 1976 Sep; 60(9):1393-4. PubMed ID: 189924
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
    Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
    Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L; Zeuli M; Sega FM; Cognetti F
    J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 244.